Medifast Inc

Análisis de la acción Medifast Inc (MED)

$12.730

-0.406 (-3.19%)Al cierre

Loading chart…
Máximo
13.220
Apertura
13.080
Precio medio ponderado por volumen
12.81
Volumen
152.10K
Capitalización
230.99M
Mínimo
12.470
Importe
1.95M
EV/EBITDA, TTM
-1.79

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. It sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources.

medifastinc.com

Análisis de IA of Medifast Inc (MED)

Mantener

Medifast Inc (MED) is currently trading at $12.53, showing a recent upward trend with a 5-day change of +3.47%. However, the company has reported significant losses, with a forward P/E of 12.48 indicating potential recovery but also reflecting ongoing challenges. The RSI is at 67.72, suggesting it may be nearing overbought territory. The main risk is the substantial net income loss of $17.5 million reported for Q3 2026, which raises concerns about its financial stability.

Recomendaciones de analistas (2)

Comprar
1 Comprar
1 Mantener
0 Vender
Actual: 12.73
Mínimo
—
Promedio
—
Máximo
—

Stephens

2026-02-19

Precio objetivo

$12

Equal Weight

DA Davidson

2025-02-19

Precio objetivo

$17

Mantener

DA Davidson

2024-11-05

Precio objetivo

$17

Mantener

DA Davidson

2024-07-22

Precio objetivo

$18

Vender

DA Davidson

2024-06-05

Precio objetivo

$18

Vender

Métricas de valoración

El PER previsto actual de Medifast Inc (MED) es 12.48, frente a su media de 5 años de 10.08.

PER previsto

Valor razonable
Media 5A P/E
10.08
P/E actual
12.48
Sobrevalorada
76.00
Infravalorada
-55.84

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
1.60
EV/EBITDA actual
-1.79
Sobrevalorada
15.94
Infravalorada
-12.73

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.72
P/S actual
0.54
Sobrevalorada
1.07
Infravalorada
0.37

Escenarios de precio de Alphio AI para MED

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%MED

$7.77

Precio del escenario

B

Base

Base · 50%MED

$7.58

Precio del escenario

B

Bajista

Bajista · 25%MED

$5.48

Precio del escenario

Cronología de eventos

2026-10-26 (ET)

08:30:00

Company Expects 2026 Revenue Between $280 Million and $300 Million

08:30:00

Sees Q4 Revenue of $55M-$75M

08:30:00

Medifast Reports Q3 Revenue of $72.05M

2026-08-27 (ET)

09:00:00

Medifast Launches Metabolic Health Institute

2026-08-03 (ET)

19:30:00

Stock Futures Broadly Higher, Oil Prices Slip

Noticias

Preguntas frecuentes sobre MED, respondidas por Alphio AI

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. It sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources. It operates in the Consumer Non-Cyclicals sector (MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS industry).

Medifast Inc (MED) is currently trading at $12.53, showing a recent upward trend with a 5-day change of +3.47%. However, the company has reported significant losses, with a forward P/E of 12.48 indicating potential recovery but also reflecting ongoing challenges. The RSI is at 67.72, suggesting it may be nearing overbought territory. The main risk is the substantial net income loss of $17.5 million reported for Q3 2026, which raises concerns about its financial stability.

2 analysts cover MED: 1 rate it Buy, 1 Hold and 0 Sell.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar